• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素在小鼠体内通过还原和葡萄糖醛酸化进行的生物转化。

Biotransformation of curcumin through reduction and glucuronidation in mice.

作者信息

Pan M H, Huang T M, Lin J K

机构信息

Institute of Biochemistry, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China.

出版信息

Drug Metab Dispos. 1999 Apr;27(4):486-94.

PMID:10101144
Abstract

Curcumin, the yellow pigment in turmeric and curry, has antioxidative and anticarcinogenic activities. In this study, we investigated the pharmacokinetic properties of curcumin in mice. After i.p. administration of curcumin (0.1 g/kg) to mice, about 2.25 microg/ml of curcumin appeared in the plasma in the first 15 min. One hour after administration, the levels of curcumin in the intestines, spleen, liver, and kidneys were 177.04, 26.06, 26.90, and 7.51 microg/g, respectively. Only traces (0.41 microg/g) were observed in the brain at 1 h. To clarify the nature of the metabolites of curcumin, the plasma was analyzed by reversed-phase HPLC, and two putative conjugates were observed. Treatment of the plasma with beta-glucuronidase resulted in a decrease in the concentrations of these two putative conjugates and the concomitant appearance of tetrahydrocurcumin (THC) and curcumin, respectively. To investigate the nature of these glucuronide conjugates in vivo, the plasma was analyzed by electrospray. The chemical structures of these metabolites, determined by mass spectrometry/mass spectrometry analysis, suggested that curcumin was first biotransformed to dihydrocurcumin and THC and that these compounds subsequently were converted to monoglucuronide conjugates. Because THC is one of the major metabolites of curcumin, we studied its stability at different pH values. THC was very stable in 0.1 M phosphate buffers of various pH values. Moreover, THC was more stable than curcumin in 0.1 M phosphate buffer, pH 7.2 (37 degrees C). These results, together with previous findings, suggest that curcumin-glucuronoside, dihydrocurcumin-glucuronoside, THC-glucuronoside, and THC are major metabolites of curcumin in vivo.

摘要

姜黄素是姜黄和咖喱中的黄色色素,具有抗氧化和抗癌活性。在本研究中,我们研究了姜黄素在小鼠体内的药代动力学特性。给小鼠腹腔注射姜黄素(0.1 g/kg)后,最初15分钟血浆中出现约2.25微克/毫升的姜黄素。给药1小时后,姜黄素在肠道、脾脏、肝脏和肾脏中的含量分别为177.04、26.06、26.90和7.51微克/克。1小时时在大脑中仅观察到微量(0.41微克/克)。为了阐明姜黄素代谢物的性质,采用反相高效液相色谱法分析血浆,观察到两种假定的共轭物。用β-葡萄糖醛酸酶处理血浆导致这两种假定共轭物的浓度降低,并分别同时出现四氢姜黄素(THC)和姜黄素。为了研究体内这些葡萄糖醛酸共轭物的性质,采用电喷雾法分析血浆。通过质谱/质谱分析确定的这些代谢物的化学结构表明,姜黄素首先生物转化为二氢姜黄素和THC,随后这些化合物转化为单葡萄糖醛酸共轭物。由于THC是姜黄素的主要代谢物之一,我们研究了其在不同pH值下的稳定性。THC在各种pH值的0.1 M磷酸盐缓冲液中非常稳定。此外,在pH 7.2(37℃)的0.1 M磷酸盐缓冲液中,THC比姜黄素更稳定。这些结果与先前的发现一起表明,姜黄素-葡萄糖苷、二氢姜黄素-葡萄糖苷、THC-葡萄糖苷和THC是姜黄素在体内的主要代谢物。

相似文献

1
Biotransformation of curcumin through reduction and glucuronidation in mice.姜黄素在小鼠体内通过还原和葡萄糖醛酸化进行的生物转化。
Drug Metab Dispos. 1999 Apr;27(4):486-94.
2
Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.姜黄素在家族性腺瘤性息肉病模型min/+小鼠中的化学预防功效及药代动力学
Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.
3
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.化学预防剂姜黄素在人及大鼠肝细胞中以及大鼠体内的代谢产物表征,及其抑制佛波酯诱导的前列腺素E2生成能力的评估。
Cancer Res. 2001 Feb 1;61(3):1058-64.
4
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.癌症患者对假定化学预防剂姜黄素的摄入:结直肠中姜黄素水平及其药效学后果的评估。
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5.
5
Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) method.使用新型超高效液相色谱(UPLC)方法对大鼠生物基质中的姜黄素及其代谢产物进行快速分析。
J Agric Food Chem. 2009 Feb 11;57(3):797-803. doi: 10.1021/jf803038f.
6
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.癌症化学预防剂姜黄素在人和大鼠肠道中的代谢。
Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):105-11.
7
Deconjugation of N-glucuronide conjugated metabolites with hydrazine hydrate--biomarkers for exposure to the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).用氢氧化肼使N-葡糖醛酸共轭代谢物脱共轭——食品中致癌物质2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)暴露的生物标志物
Food Chem Toxicol. 2007 May;45(5):863-70. doi: 10.1016/j.fct.2006.11.006. Epub 2006 Nov 16.
8
Tetrahydrocurcumin in plasma and urine: quantitation by high performance liquid chromatography.血浆和尿液中的四氢姜黄素:采用高效液相色谱法定量分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):206-12. doi: 10.1016/j.jchromb.2005.07.026.
9
Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.大鼠口服和腹腔注射硝基阿司匹林(NCX 4016)后一氧化氮的释放与分布
Life Sci. 2004 May 14;74(26):3291-305. doi: 10.1016/j.lfs.2003.11.018.
10
Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs.(Lipocurc™)脂质体姜黄素和四氢姜黄素在比格犬静脉输注两小时和八小时后的组织分布。
Anticancer Res. 2012 Oct;32(10):4359-64.

引用本文的文献

1
Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits - a comprehensive review.姜黄素,姜黄的一种活性成分:生物学活性、营养特性、免疫学、生物利用度及对人类健康的益处——综述
Front Immunol. 2025 Aug 21;16:1603018. doi: 10.3389/fimmu.2025.1603018. eCollection 2025.
2
Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery.姜黄素作为治疗糖尿病神经病变的一种有前景的治疗药物:从分子机制到功能恢复
Diabetol Metab Syndr. 2025 Aug 5;17(1):314. doi: 10.1186/s13098-025-01884-5.
3
Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases.
姜黄素在神经退行性疾病治疗中的药理作用、分子机制及提高生物利用度的策略
Front Pharmacol. 2025 Jul 10;16:1625821. doi: 10.3389/fphar.2025.1625821. eCollection 2025.
4
Immunomodulatory Effects of Curcumin on CAR T-Cell Therapy.姜黄素对嵌合抗原受体T细胞疗法的免疫调节作用。
Antioxidants (Basel). 2025 Apr 10;14(4):454. doi: 10.3390/antiox14040454.
5
Esterified Indole-3-propionic Acid: A Novel Inhibitor against Cholinesterase Identified through Experimental and Computational Approaches.酯化吲哚-3-丙酸:一种通过实验和计算方法鉴定出的新型胆碱酯酶抑制剂。
ACS Omega. 2025 Mar 1;10(9):9073-9087. doi: 10.1021/acsomega.4c08149. eCollection 2025 Mar 11.
6
Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders.探索姜黄素在减轻氧化应激以缓解脂质代谢紊乱中的作用。
Front Pharmacol. 2025 Jan 30;16:1517174. doi: 10.3389/fphar.2025.1517174. eCollection 2025.
7
Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats.包裹在聚酰胺-胺(PAMAM)树枝状大分子中的姜黄素用于大鼠缺血性中风的治疗。
Front Cell Dev Biol. 2025 Jan 6;12:1467417. doi: 10.3389/fcell.2024.1467417. eCollection 2024.
8
Design and synthesis of a novel curcumin-combretastatin A4 molecular skeleton: two pharmacophores.新型姜黄素-康普瑞他汀A4分子骨架的设计与合成:两个药效基团。
RSC Adv. 2024 Nov 20;14(50):37227-37233. doi: 10.1039/d4ra06618a. eCollection 2024 Nov 19.
9
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.姜黄素在神经系统疾病中的研究进展:调节氧化应激的作用及临床研究
Front Pharmacol. 2024 Nov 1;15:1496661. doi: 10.3389/fphar.2024.1496661. eCollection 2024.
10
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer.姜黄素:头颈癌预防与治疗中的一种潜在武器。
ACS Pharmacol Transl Sci. 2024 Oct 14;7(11):3394-3418. doi: 10.1021/acsptsci.4c00518. eCollection 2024 Nov 8.